Living With Lung Cancer: Ask Me Anything

Living with lung cancer isn’t just about treatment plans and statistics—it’s about the raw, real, messy truth of what it means to survive.No topic is off-limits. No question is too uncomfortable. No experience is too raw to share.

Living With Lung Cancer: Ask Me Anything is a health podcast hosted by Lung Cancer Foundation of America, with 13 episodes on record and a Required Pod Score of 80.

Lung Cancer Foundation of America hosts Living With Lung Cancer: Ask Me Anything, a health show with 13 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Living With Lung Cancer: Ask Me Anything

  IV vs. Subcutaneous Cancer Treatment: What Patients Should Ask

  Sep 24, 202621 min

  What's it really like to trade an IV infusion chair for a quick injection under the skin? Host James Hiter talks with fellow patient advocate Stephanie Williams — a former registered nurse now living with ALK+ lung cancer — about subcutaneous (SubQ) drug delivery. Stephanie draws on both her nursing background and her own treatment journey to explain how SubQ compares to IV and intramuscular delivery, why it's gaining ground in lung cancer care, and how to bring it up with your own oncologist. Guests: James Hiter (Host) is a lung cancer patient advocate, LCFA board member, and member of LCFA's Speakers Bureau. He is living with KRAS G12D-driven lung cancer. Stephanie Williams (Guest) is a longtime LCFA volunteer and Speakers Bureau member. Diagnosed with stage 2 non-small cell lung cancer (ALK+) at age 37, she is a former registered nurse and mother who underwent surgery and chemotherapy before transitioning to oral targeted therapy. She now advocates for patients navigating treatment options and biomarker testing. Show Notes - https://lcfamerica.org/wp-content/uploads/2026/09/AMA-2026-Fall-Subcutaneous-Treatment-Show-Notes.pdf Transcript - https://lcfamerica.org/wp-content/uploads/2026/09/AMA-2026-Fall-Subcutaneous-Treatment-Transcript.pdf Watch Video - https://youtu.be/DMWtaCmEFio

  ListenShow Notes
• 

  Living With Lung Cancer: Ask Me Anything

  Small Cell Lung Cancer Maintenance Therapy: A Survivor's Guide

  Sep 10, 202618 min

  What happens after first-line chemotherapy works for small cell lung cancer? Host James Hiter sits down with long-term survivor and patient advocate Montessa Lee to talk about maintenance therapy — what it is, who it's for, and the questions every patient should bring to their care team. They cover quality of life, managing side effects, and why staying on treatment can be a proactive, hopeful step rather than a setback. Guests: James Hiter – Host, living with lung cancer Montessa Lee – Long-term small cell lung cancer survivor, LCFA Speakers Bureau member, and patient advocate Show Notes - https://lcfamerica.org/wp-content/uploads/2026/09/AMA-SCLC-Maintenance-Therapy-Show-Notes.pdf Transcript - https://lcfamerica.org/wp-content/uploads/2026/09/AMA-Maintenance-Therapy-SLCL-Transcript.pdf Watch Video - https://youtu.be/zJqDWQNrbv4

  ListenShow Notes
• 

  Living With Lung Cancer: Ask Me Anything

  SubQ: A Simpler, Less Disruptive Path to Lung Cancer Treatment

  May 28, 202618 minS0

  <p>What if "one more medication" didn't have to feel like another punch? Host James Hiter sits down with ALK+ lung cancer survivor and patient advocate Stephanie Williams to demystify subcutaneous (SubQ) treatment delivery.</p> <p>Diagnosed at 37 with stage 2 non-small cell lung cancer, Stephanie brings both her patient experience and her background as a registered nurse to this conversation. She explains what SubQ delivery is, how it compares to traditional IV infusion, what to expect during an injection, and why this option can mean less anxiety, fewer infection risks, and more time back with family.</p> <p>You'll also...

  ListenShow Notes
• 

  Living With Lung Cancer: Ask Me Anything

  14 Years Strong: Lysa Buonanno on Clinical Trials, ROS1, and Living Long-Term with Lung Cancer

  May 14, 202652 minS0

  <p>What does 14 years of living with stage 4 lung cancer actually look like? Host Annabelle Gurwitch welcomes patient advocate, mentor, and new grandmother Lysa Buonanno for a deeply honest conversation about long-term survival with ROS1-positive lung cancer.</p> <p>Diagnosed at age 40 before biomarker testing was standard of care, Lysa learned about precision medicine through an online patient group, not her doctor. That knowledge led her to switch oncologists, undergo surgery for biomarker testing, and ultimately access targeted therapy that gave her five more years before progression. Today, she's on her fifth line of treatment via a Phase 1 clinical...

  ListenShow Notes
• 

  Living With Lung Cancer: Ask Me Anything

  Scanxiety: Managing Drug Resistance Fears with ALK+ Patient Jaymie Knox

  Apr 30, 202625 minS0

  <p>What goes through your mind in the days before a lung cancer scan? In this honest conversation, host James Hiter talks with ALK+ patient advocate Jaymie Knox about scanxiety, drug resistance, and the mental gymnastics of living with targeted therapy.</p> <p>Now seven years into treatment with alectinib, Jaymie shares why having a Plan B matters, how she keeps cancer from taking over her headspace, and why the language we use, "the medication failed me," not the other way around, makes a real difference for patients.</p> <p>Together, James and Jaymie talk about:</p> <p><br> Why...

  ListenShow Notes

Recent guests on Living With Lung Cancer: Ask Me Anything. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.